{
  "id": 8355206,
  "title": "Tempus AI chief accounting officer sells $529,650 in stock",
  "url": "https://urgent.news/2026/09/19/tempus-ai-chief-accounting-officer-sells-529-650-in-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-19T01:45:55.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/tempus-ai-chief-accounting-officer-sells-529650-in-stock-93CH-4908030"
  },
  "original_language": "en",
  "account": "Tempus AI's Chief Accounting Officer, Ryan M. Bartolucci, divested 7,062 shares of the company's Class A common stock on September 17, 2026, amounting to $529,650 at a rate of $75 per share. The stock's recent surge of nearly 32%, trading at $77.84, has led to speculation that the stock is overvalued. With this sale, Mr. Bartolucci now owns 60,804 shares of Tempus AI Class A common stock. The transaction was carried out in compliance with a Rule 10b5-1 trading plan adopted by Mr. Bartolucci on June 5, 2026. Investors with access to InvestingPro receive 12 additional exclusive tips about Tempus AI, along with financial health scores and detailed analysis. Tempus AI has been under scrutiny in recent news, with H.C. Wainwright raising its price target to $66 from $56 and maintaining a Buy rating, following positive results from Merck and Moderna’s Phase 3 INTerpath-001 trials. Piper Sandler upgraded Tempus AI to Overweight from Neutral, with a price target of $76, citing the benefits of the Personalis acquisition. Cantor Fitzgerald also initiated coverage with an Overweight rating and a price target of $80, projecting a potential upside of 28%. Rothschild Redburn opted for a Neutral rating and a price target of $67, highlighting Tempus AI's range of genomic testing services.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Tempus AI CEO, data Ryan Fukushima sells $49,000 in stock",
        "url": "https://urgent.news/2026/09/19/tempus-ai-ceo-data-ryan-fukushima-sells-49-000-in-stock",
        "published": "2026-09-19T01:45:55.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}